Skip to main content

SPATA25 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85801

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-85801-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the middle region of human SPATA25. Peptide sequence: VRQLESLGWDNGYSRSRAPDLGGPSRPRPLMLCGLSPRVLPVPSEAVGKE The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for SPATA25 Antibody

Western Blot: SPATA25 Antibody [NBP2-85801]

Western Blot: SPATA25 Antibody [NBP2-85801]

Western Blot: SPATA25 Antibody [NBP2-85801] - Host: Rabbit. Target Name: C20ORF165. Sample Tissue: Lung Tumor lysates. Antibody Dilution: 1ug/ml

Applications for SPATA25 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: SPATA25

Alternate Names

C20orf165, Chromosome 20 Open Reading Frame 165, DJ337O18.8, Spermatogenesis Associated 25, Testis-Specific Gene 23 Protein, TSG23

Gene Symbol

SPATA25

Additional SPATA25 Products

Product Documents for SPATA25 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SPATA25 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...